Alzheimer’s disease (AD) is the most common form of dementia accounting for over 70-80% of the cases and affecting 50 millions of people worldwide. This technology provides a cost-effective, simple, direct yet sensitive platform for early neurodegenerative diseases detection and diagnostics.
Several biomarkers in cerebrospinal fluid (CSF) have been recognized and established for AD diagnosis with high diagnostic accuracy over 85%. However, the collection of CSF is invasive and causes discomfort and side effects on patients. This technology provides a non-invasive solution for early Alzheimer’s disease diagnosis.
Aspiring to be a leading, research-led, liberal arts University in Asia, Hong Kong Baptist University is committed to conducting world-leading investigations that extends the frontiers of knowledge, tackles global challenges and benefits the community at home and abroad.
Pursuing research excellence is one of the priorities of the University’s Institutional Strategic Plan 2018-2028. The University keeps enhancing its capacity and strength to produce world-class research with an aim to bring significant impact to the society.